Chronic inflammatory demyelinating polyradiculoneuropathy: Superiority of protein A immunoadsorption over plasma exchange treatment

Transfusion Science

Volumn 19, Issue SUPPL., 1997, Pages 33-38

  Ullrich, Heidrun ^a   Mansouri Taleghani, Behrouz ^b   Lackner, Karl J ^a   Schalke, Berthold ^a   Bogdahn, Ulrich ^a   Schmitz, Gerd ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PROTEIN A;

CASE REPORT; COMPARATIVE STUDY; CONFERENCE PAPER; DEMYELINATING NEUROPATHY; DISEASE COURSE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOADSORPTION; LYMPHOMA; MALE; MUSCLE STRENGTH; PLASMAPHERESIS; PROTEIN DEPLETION; RELAPSE; RETROSPECTIVE STUDY; WALKING;

EID: 0031929420     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(97)00100-8     Document Type: Conference Paper

References (15)

1. Hartung HP, Toyka KV: Immune reactions in the peripheral nervous system, in Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds): Peripheral Neuropathy, 3rd edn. Philadelphia, W.B. Saunders, 1993, pp. 433-434.
2. Khalili-Shirazi A, Atkinson P, Gregson N, Hughes RAC: Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J of Neuroimmunol 1993; 46:245-252.
3. Van-den-Berg LH, Mollee I, Wokke JH, Logtenberg T: Increased frequencies of HPRT mutant T-lymphocytes in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T-cells in the etiopathogenesis of peripheral demyelinating diseases. J Neiroimmunol 1995; 58 (1):37-42.
4. Dyck PJ, Daube J, O'Brien P, et al.: Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986; 314:461-65.
5. Mendell JR: Chronic inflammatory demyelinating polyradiculopathy. Annu Rev Med 1993; 44:211-219.
6. Simmons Z, Albers JW, Bromberg MB, Feldman EL: Long-term follow up of patients with chronic inflammatory demyelinating polyradiculopathy, without and with monoclonal gammopathy. Brain 1995; 118:359-368.
7. McKhann GM, Griffin JW, Cornblath DR, et al.: Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988; 28:347-353.
8. Heininger K, Gibbels E, Besinger U, et al.: Role of therapeutic plasmapheresis in chronic inflammatory demyelinating polyneuropathy. Apheresis 1990; 275-281.
9. Choudhary PP, Hughes RAC: Long term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. Q J Med 1995; 88:493-502.
10. Hughes RAC, Britton T, Richards M: Effects of lymphoma on the peripheral nervous system. J of Royal Soc of Med 1994; 87:526-530.
11. Osterman PO, Fagius J, Lundemo G, et al.: Beneficial effects of plasma exchange in acute inflammatory polyneuropathy. Lancet 1984; 8:1296-1298.
12. French cooperative group in plasma exchange in Guillain-Barré syndrome: Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacemant fluids. Ann Neurol 1987; 22:753-761.
13. The Guillain-Barré Syndrome Study Group: Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985; 35:1096-1104.
14. van der Mèché FG, Schmitz PI: A randomised trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med 1992; 326:1123-1129.
15. Hughes RAC: Plasma exchange/sandoglobulin Guillain-Barré syndrome study group: Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997; 349:225-230.